A double-blind, placebo-controlled trial of donepezil in patients with Parkinson's Disease and related dementia

被引：0
|
作者：
Brashear, A
Kuhn, ER
Lane, KA
Farlow, MR
Unverzagt, FW
机构：
来源：
NEUROLOGY | 2004年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A524 / A525
页数：2
相关论文
共 50 条
  • [1] Donepezil treatment in Parkinson's disease with dementia: A double-blind, placebo-controlled crossover study
    Aarsland, D
    Larsen, JP
    Janvin, C
    Laake, K
    NEUROLOGY, 2001, 56 (08) : A128 - A128
  • [2] Donepezil for dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study.
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, H
    Treischmann, M
    Reichwein, S
    Simuni, T
    MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1133
  • [3] Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
    Aarsland, Dag
    Ballard, Clive
    Walker, Zuzana
    Bostrom, Fredrik
    Alves, Guido
    Kossakowski, Katja
    Leroi, Iracema
    Pozo-Rodriguez, Francisco
    Minthon, Lennart
    Londos, Elisabet
    LANCET NEUROLOGY, 2009, 8 (07): : 613 - 618
  • [4] Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
    Emre, Murat
    Tsolaki, Magda
    Bonuccelli, Ubaldo
    Destee, Alain
    Tolosa, Eduardo
    Kutzelnigg, Alexandra
    Ceballos-Baumann, Andres
    Zdravkovic, Slobodan
    Bladstrom, Anna
    Jones, Roy
    LANCET NEUROLOGY, 2010, 9 (10): : 969 - 977
  • [5] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    Rogers, SL
    Farlow, MR
    Doody, RS
    Mohs, R
    Friedhoff, LT
    Albala, B
    Baumel, B
    Booker, G
    Dexter, J
    Farmer, M
    Feighner, JP
    Ferris, S
    Gordon, B
    Gorman, DG
    Hanna, G
    Harrell, LE
    Hubbard, R
    Kennedy, J
    McCarthy, J
    Scharre, DW
    Schaerf, F
    Schneider, L
    Seltzer, B
    Siegal, A
    Stark, SR
    Strauss, A
    Walshe, TM
    NEUROLOGY, 1998, 50 (01) : 136 - 145
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [7] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [8] Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
    Jankovic, Joseph
    Watts, Ray L.
    Martin, Wayne
    Boroojerdi, Babak
    ARCHIVES OF NEUROLOGY, 2007, 64 (05) : 676 - 682
  • [9] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [10] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
12345